Institutional Oversight of Faculty-Industry Consulting Relationships in U.S. Medical Schools: A Delphi Study

Zinner D. E. Bolcic-Jankovic D. Clarridge B. Blumenthal D. Campbell E. G. , “Participation of Academic Scientists in Relationships with Industry,” Health Affairs 28, no. 6 (2009): 1814–1825; Menachemi N. Morrisey M. A. Ginter P. M. , “Outside Consulting Income by University Faculty in Health Administration,” Journal of Health Administration Education 27, no. 4 (2010): 297–310.

Id. ( Zinner ).

Mowatt G. L. Shirran J. M. Grimshaw D. Rennie A. Flanagin V. Yank G. MacLennan P. C. Gotzsche P. C. Bero L. A. , “Prevalence of Honorary and Ghost Authorship in Cochrane Reviews,” JAMA 287, no. 21 (2002): 2769–2771; Psaty B. M. Rennie D. , “Clinical Trial Investigators and Their Prescribing Patterns: Another Dimension to the Relationship between Physician Investigators and the Pharmaceutical Industry,” JAMA 299, no. 23 (2006): 1813–1817.

United States Senate Committee on Finance, Use of Educational Grants by Pharmaceutical Manufacturers (Washington, D.C.: U.S. Government Printing Office, April 2007); United States Senate Committee on Finance Minority Staff Report, Ghostwriting in Medical Literature (U.S. Washington, D.C.: Senate Committee on Finance, June 2010); United States General Accounting Office (now the U.S. Government Accountability Office), HHS Direction Needed to Address Financial Conflicts of Interest , Report to the Ranking Minority Member, Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions, U.S. Senate (Washington, D.C.: Government Accountability Office, 2001); Medicare Payment Advisory Committee (MedPAC), Public Reporting of Physicians' Financial Relationships with Drug and Device Manufacturers, Hospitals, and ASCs, MedPAC public meeting, March 5, 2008 (Washington, D.C.: MedPAC, 2008).

Ross J. S. Hill K. P. Egilman D. S. Krumholz H. M. , “Guest Authorship and Ghost-Writing in Publications Related to Rofecoxib: A Case Study of Industry Documents from Rofexocib Litigation,” JAMA 299, no. 15 (2008): 1800–1812; Hill K. P. Ross J. S. Egilman D. S. Krumholz H. M. , “The ADVANTAGE Seeding Trial: A Review of Internal Documents,” Annals of Internal Medicine 149, no. 4 (2008): 251–258.

Institute of Medicine, Committee on Conflict of Interest in Medical Research, Education, and Practice, Conflict of Interest in Medical Research, Education, and Practice (Washington, D.C.: National Academies Press, 2009): At 6.

Liang B. A. Mackey T. , “Confronting Conflict: Addressing Institutional Conflicts of Interest in Academic Medical Centers,” American Journal of Law & Medicine 36, no. 1 (2010): 136–187; Shim D. S. Spence R. G. , “Industry Reimbursement for Entering Patients into Clinical Trials: Legal and Ethical Issues,” Annals of Internal Medicine 115, no.2 (1991): 148–151.

Dickersin K. , “The Existence of Publication Bias and Risk Factors for Its Occurrence,” JAMA 263, no. 10 (1990): 1385–1389.

Schulman K. A. Rubenstein L. E. Glick H. A. Eisenberg J. M. , “Relationships between Sponsors and Investigators in Pharmacoeconomic and Clinical Research,” Pharmacoeconomics 7, no. 3 (1995): 206–220; Blumenthal D. Campbell E. G. Anderson M. S. Causino N. Louis K. S. , “Withholding Research Results in Academic Life Science: Evidence from a National Survey of Faculty,” JAMA 277, no. 15 (1997): 1224–1228; Wise J. , “Research Suppressed for Seven Years by Drug Company,” BMJ 314, no. 7088 (1997): 1145.

Weatherall D. , “Problems for Biomedical Research at the Academia-Industrial Interface,” Science and Engineering Ethics 9, no. 1 (2003): 43–48.

Blumenthal D. , “Doctors and Drug Companies,” New England Journal of Medicine 351, no. 18 (2004): 1885–1890; Angell M. , “Is Academic Medicine for Sale?” New England Journal of Medicine 342, no. 20 (2000): 1516–1518; Bodenheimer T. , “Uneasy Alliance: Clinical Investigators and the Pharmaceutical Industry,” New England Journal of Medicine 342, no. 20 (2000): 1539–1544.

See Schulman , supra note 9; Mello M. M. Clarridge B. R. Studdert D. M. , “Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry,” New England Journal of Medicine 352, no. 21 (2005): 2202–2210.

Lipsitch M. , “The Hidden Risk to Academic Freedom in Corporate Consulting Contracts,” Chronicle of Higher Education , June 27, 2010 [cited August 22, 2014], available at <http://chronicle.com/article/The-Hidden-Risk-to-Academic/66050/> (last visited April 29, 2015).

Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc., 563 U.S. No. 09–1159.

See Lipsitch , supra note 13.

Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought. 42 C.F.R. Part 50, Subpart F (2011) [cited August 22, 2014].

Association of American Medical Colleges, Task Force on Financial Conflicts of Interest in Clinical Research, Protecting Subjects, Preserving Trust, Promoting Progress – Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research , Washington, D.C., December 2001, available at <https://www.aamc.org/download/75302/data> (last visited April 29, 2015).

See Institute of Medicine, supra note 6.

International Committee of Medical Journal Editors, “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Updated 2010 [cited August 22, 2014],” available at <http://www.icmje.org/> (last visited April 29, 2015).

Centers for Medicare and Medicaid Services, Medicare, Medicaid, Children's Health Insurance Programs, Transparency Reports and Reporting of Physician Ownership or Investment Interests , 42 CFR 402, 42CFR 403 CMS-2011-0191, Washington, D.C., 2013 [cited August 22, 2014], available at <https://federalregister.gov/a/2013–02572> (last visited April 29, 2015).

The Business–Higher Education Forum, Working Together, Creating Knowledge: University-iIndustry Research Collaboration Initiative , Washington, D.C., American Council on Education, 2001, available at <http://www.eric.ed.gov/ERICWebPortal/search/detailmini.jsp?_nfpb=true&_&ERICExtSearch_SearchValue_0=ED457765&ERICExtSearch_SearchType_0=no&accno=ED457765> (last visited April 29, 2015).

See Association of American Medical Colleges, supra note 17.

American Association of University Professors, Recommended Principles to Guide Academic-Industry Relations (Urbana, IL: University of Illinois Press, 2014).

Institute on Medicine as a Profession, Consulting and Honoraria: Best Practices for Academic Medical Centers , October 10, 2013, available at <http://imapny.org/wp-content/themes/imapny/File%20Library/Best%20Practice%20toolkits/Best-Practices_Consulting-and-Honoraria.pdf> (last visited April 29, 2015).

Lindstone H. Turloff M. , The Delphi Method: Techniques and Applications (London: Addison Wesley, 1975); Adler M. Ziglio E. , Gazing into the oracle: The Delphi Method and Its Application to Social Policy and Public Health (London: Jessica Kingsley Publishers, 1996).

Minter R. M. Angelos P. Coimbra R. Dale P. de Vera M. E. Hardacre J. , “Ethical Management of Conflict of Interest: Proposed Standards for Academic Surgical Societies,” Journal of the American College of Surgeons 213, no. 5 (2011): 677–682.

Smith D. , “Establishing National Priorities for Australian Occupational Health and Safety Research,” Journal of Occupational Health 52, no. 4 (2010): 241–248; Moscovice I. Armstrong P. Shortell S. Bennett R. , “Health Services Research for Decision-Makers: The Use of the Delphi Technique to Determine Health Priorities,” Journal of Health Politics Policy & Law 2, no. 3 (1977): 388–310.

Pincus T. Miles C. Froud R. Underwood M. Carnes D. Taylor S. J. C. , “Methodological Criteria for the Assessment of Moderators in Systematic Reviews of Randomised Controlled Trials: A Consensus Study,” BMC Medical Research Methodology 11, no. 14 (2011), available at <http://www.biomedcentral.com/1471–2288/11/14> (last visited May 8, 2015).

Banks D. E. Shi R. McLarty J. Cowl C. T. Smith D. Tarlo S. M. , “American College of Chest Physicians Consensus Statement on the Respiratory Health Effects of Asbestos,” Chest 135, no. 6 (2009): 169–127; De Vos E. Spivak H. Hatmaker-Flanigan E. Sege R. D. , “A Delphi Approach to Reach Consensus on Primary Care Guidelines Regarding Youth Violence Prevention,” Pediatrics 118, no. 4 (2006): e1109–e1115; Akins R. B. , “A Process-Centered Tool for Evaluating Patient Safety Performance and Guiding Strategic Improvement,” in Henriksen K. Battles J. B. Marks E. S. Lewin D. I. , eds., Advances in Patient Safety: From Research to Implementation Volume 4: Programs, Tools, and Products (Rockville: Agency for Healthcare Research and Quality, 2005); Hawryluck L. A. Harvey W. R. Lemieux-Charles L. Singer P. A. , “Consensus Guidelines on Analgesia and Sedation in Dying Intensive Care Patients,” BMC Medical Ethics 3, no. 3 (2002): E3.

Fitch K. Bernstein S. J. Aguilar M. S. Burnand B. LaCalle J. R. Lazaro P. , The RAND/UCLA Appropriateness Method User's Manual (Santa Monica: RAND, 2001).

United Nations International Development Organization, Kerstin Cuhls, Fraunhofer Institute for Systems and Innovation Research (DE), The Delphi Method , citing Wechsler W. , Delphi-Methode, Gestaltung und Potential für betriebliche Prognoseprozesse, Schriftenreihe Wirtschaftswissenschaftliche Forschung und Entwicklung, München (1978) [cited August 22, 2014], available at <http://www.unido.org/fileadmin/import/16959_DelphiMethod.pdf> (last visited April 29, 2015).

See Adler Ziglio , supra note 25.

Brown B. B. , Delphi Process: A Methodology Used for the Elicitation of Opinion of Experts (Santa Monica: RAND Corporation, 1968).

Mello M. M. Murtagh L. Joffe S. Taylor P. L. Greenberg Y. Campbell E. G. , “Beyond Financial Conflicts of Interest: Institutional Oversight of Faculty Consulting Agreements at Schools of Medicine and Public Health,” Working Paper, September 18, 2014.

See Mello , supra note 12.

See Mello , supra note 34.

Chimonas S. Evarts S. D. Littlehale S. K. Rothman D. J. , “Managing Conflicts of Interest in Clinical Care: The ‘Race to the Middle’ at U.S. Medical Schools,” Academic Medicine 88, no. 10 (2013): 1464–1470.

Rothman D. J. Chimonas S. , “New Developments in Managing Physician-Industry Relationships,” JAMA 300, no. 9 (2008): 1067–1069.

American Bar Association, Center for Professional Responsibility, Model Rules of Professional Conduct, Rule 1.7, Conflict of Interest: Current Clients [cited February 25, 2014], available at <http://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professional_conduct/model_rules_of_professional_conduct_table_of_contents.html> (last visited April 29, 2015).